Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance

Go back to Introgen Therapeutics, Inc. (INGN) Tops Q2 EPS by 4c, Raises Guidance
INOGEN (NASDAQ: INGN) Delayed: 5.85 +0.04 (0.69%)
Previous Close $5.81    52 Week High $64.37 
Open $5.84    52 Week Low $28.81 
Day High $5.90    P/E N/A 
Day Low $5.80    EPS $-0.36 
Volume 72,967